Products for Research Use Only
RegisterLogin

DNDI-0690

CAT: 0804-HY-156132Size: 1 EachDry Ice: NoHazardous: No
Product image 1
1 / 1
CAT#:0804-HY-156132Size:1 Each
Selected
24/48H Stock Items & 2 to 6 Weeks non Stock Items.
Quick Request Actions
Description
DNDI-0690 is a potent orally active analogue of DNDI-VL-2098, exhibiting potent activity against cutaneous leishmaniasis (CL) . DNDI-0690 shows potent in vitro activity against CL-causing Leishmania species (EC50 = 0.17 μM against visceral leishmaniasis (VL), and L. major CL. DNDI-0690 can be used for CL research[1].
CAS Number
2097881-13-3
UNSPSC
12352209
Target
Parasite
Related Pathways
Anti-infection
Applications
COVID-19-immunoregulation
Field of Research
Infection
Smiles
FC(C=C1)=CC=C1C2=NC=C(C=C2)OC[C@@H]3OC4=NC([N+]([O-])=O)=CN4CC3
Molecular Formula
C18H15FN4O4
Molecular Weight
370.33
References & Citations
[1]Wijnant GJ, et al. Pharmacokinetics and Pharmacodynamics of the Nitroimidazole DNDI-0690 in Mouse Models of Cutaneous Leishmaniasis. Antimicrob Agents Chemother. 2019 Aug 23;63 (9) :e00829-19.
Shipping Conditions
Room temperature
Scientific Category
Reference compound1
Clinical Information
No Development Reported

Related Products

CatalogName
HY-139854-01DNDI-6148
HY-124623DNDI-8219
HY-176264DNDI-6510
HY-162066-01DNDI-6174
HY-129819(Rac) -DNDI-8219
HY-115663C620-0696
HY-15857-01CW-069
HY-151629-01MRV03-069
HY-101544ARQ 069
HY-148242-01BAY-069

Alternative Products

CatalogName
GTR19274382-01DNDI-0690
BA2117-5DNDI-6174
T39746-01DNDI-6148
GTR19263096-01DNDI-6510
MBS5773769DNDI-8219
MBS1051514Recombinant Probable citrate synthase, mitochondrial (LinJ18.0690, LinJ_18_0690), partial

Popular Products